Likewise, expression of ARG1 and ARG2 enzymes in both cancer and immunosuppressive cells leads to the depletion of another important amino acid, L-arginine, from the TME, suppressing T cell–mediated anti-tumor immunity [65, 69]. This evidence concerns the gene ARG2 and neoplasm.